XVIVO Xvivo Perfusion AB (publ)
214.40SEK+0.37%Mkt Cap: 645.99M $P/E: 76.031d ago
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Industry Peers
Medical Devices$174.36BUSDP/E 32.3
$112.53BUSDP/E 21.6
$109.40BUSDP/E 29.6
$61.45BUSDP/E 17.2
$50.23BUSDP/E 51.9
$46.06BUSDP/E 19.2
$32.79BUSDP/E 34.5
$29.90BUSDP/E 15.1
$23.37BUSDP/E 17.8
$22.58BUSDP/E 18.5
$20.58BUSDP/E 25.8
$17.06BUSDP/E 27.9
$17.47BUSDP/E 22.2
$12.73BUSD
$12.49BUSDP/E 77.9
$11.27BUSDP/E 18.3
$10.28BUSDP/E 19.6
$10.16BUSDP/E 48.1
$9.81BUSDP/E 27.8
$9.73BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
MMedtech Magazine | ||
DDagens PS | ||
Xvivo Perfusion AB (XVIPF) Q2 2026 Earnings Call Highlights: Strong Organic Growth Amidst ... Xvivo Perfusion AB (XVIPF) reports robust sales growth and a stable cash position, while navigating challenges in service segment and regulatory approvals. | ||
BBiostock | ||
FFastighetsvärlden | ||